Literature DB >> 21327423

Healthcare-associated infections in rheumatology in Japan.

Masahiro Iwamoto1, Takeshi Kamimura, Takao Nagashima, Yasuyuki Kamata, Yoko Aoki, Sachiko Onishi, Seiji Minota.   

Abstract

Prospective observational study was performed to elucidate the incidence and characteristics of healthcare-associated infections in a university hospital for rheumatology care. In this study, a total of 1,226 patients were prospectively enrolled between March 2004 and February 2006 and between April 2008 and December 2008. Healthcare-associated infection was defined as an infection developing after the third day of admission to the rheumatology ward. We detected the following 54 healthcare-associated infections in 49 patients: respiratory tract infection, 14 cases; Clostridium difficile infection, 2 cases; urinary tract infection, 4 cases; bloodstream infection, 9 cases; skin infection, 2 cases; reactivation of latent cytomegalovirus infection, 6 cases; herpes zoster infection, 5 cases; Candida infection, 7 cases; others, 4 cases. The incidence rate of respiratory tract infection was the highest. Methicillin-resistant Staphylococcus aureus was the causative bacterium in 21% of respiratory tract infections cases. Bloodstream infection due to the insertion of a catheter and opportunistic infection by a latent virus were also occurred commonly. Respiratory tract infection, bloodstream infection and opportunistic infection by a latent virus were the most common causes of healthcare-associated infection in rheumatology. It is important to pay more attention to healthcare-associated infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21327423     DOI: 10.1007/s00296-011-1829-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  6 in total

1.  Clinical and bacteriologic study of eighty-six patients with systemic lupus erythematosus complicated by infections.

Authors:  Z Li; L Chen; R Tao; X Fan
Journal:  Chin Med J (Engl)       Date:  1998-10       Impact factor: 2.628

2.  Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus.

Authors:  J E Navarro-Zarza; E Alvarez-Hernández; J C Casasola-Vargas; E Estrada-Castro; R Burgos-Vargas
Journal:  Lupus       Date:  2009-11-02       Impact factor: 2.911

3.  Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia.

Authors:  R Coello; A Charlett; V Ward; J Wilson; A Pearson; J Sedgwick; P Borriello
Journal:  J Hosp Infect       Date:  2003-01       Impact factor: 3.926

Review 4.  Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients.

Authors:  K N Duffy; C M Duffy; D D Gladman
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

5.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes.

Authors:  W van der Bij; R Torensma; W J van Son; J Anema; J Schirm; A M Tegzess; T H The
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

Review 6.  Nosocomial or hospital-acquired infections: an overview.

Authors:  Robin B McFee
Journal:  Dis Mon       Date:  2009-07       Impact factor: 3.800

  6 in total
  2 in total

Review 1.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

Review 2.  The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review.

Authors:  Thomas V Riley; Tomomi Kimura
Journal:  Infect Dis Ther       Date:  2018-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.